Use Case · Metabolic Health
How steady you feel between meals.
Hydrogen therapy for metabolic health
You don’t notice metabolism doing its work — until you notice the days you feel uneven. Research suggests molecular hydrogen may support what happens at the level of the cellular machinery that handles your daily fuel, the quiet oxidative work that goes on whether you’re paying attention or not.
Most of us notice metabolism only by absence. The afternoon that doesn’t dip. The morning that feels easy. The hour after a meal that doesn’t ask anything of us. The system is meant to be invisible — it runs quietly underneath the day, switching between the fuels available to it, adjusting to what we ate and when we slept and how hard we moved. When it’s working, we don’t think about it. When it’s not, we feel it as steadiness lost.
What’s interesting is that the same selectivity that makes molecular hydrogen worth paying attention to in the first place — its ability to neutralise the most damaging free radicals while leaving useful ones alone — turns out to matter at the level of the mitochondria, the cellular machinery where metabolism actually happens. The early human research is small but specific, and one 2025 trial in particular has been worth slowing down for.
This page is about what a growing body of peer-reviewed research has explored on molecular hydrogen and daily metabolic function. What it suggests. What it doesn’t. And the position we’ve taken as we’ve watched the evidence build.
New to molecular hydrogen? Start with what is hydrogen therapy.
The Research
What the research suggests.
A randomised controlled trial published in Medical Gas Research in 2025 looked at what 60 minutes of molecular hydrogen inhalation does to resting metabolism in healthy adults. Twenty physically active women, randomised double-blind placebo-controlled crossover, inhaling either hydrogen or ambient air through a nasal cannula at 300 ml/min for an hour while at rest. The researchers measured respiratory exchange ratio — the standard indirect-calorimetry measure of which fuel the body is burning at any given moment. Hydrogen inhalation significantly decreased respiratory exchange ratio compared with placebo, across every 15-minute interval of the hour. In plain terms: more fat oxidation, less carbohydrate. Specifically interesting was that the effect was larger in participants with higher body fat percentage — the metabolic shift tracked with how much there was to shift.
A respiratory exchange ratio is one of those measurements that sounds technical but isn’t. An RER of 0.85 means the body is burning a mixed fuel of carbohydrate and fat. Closer to 0.70 means more fat being oxidised. Closer to 1.00 means more carbohydrate. The researchers describe a decrease from 0.85 to 0.80 as roughly a 16% shift toward lipid utilisation. The Grepl 2025 trial saw that kind of shift over a single hour-long session.
The mechanism this trial was probing has been building for nearly twenty years. The foundational paper sits in Nature Medicine in 2007 — the one that established why hydrogen is worth studying at all. Molecular hydrogen selectively neutralises the hydroxyl radical and peroxynitrite — the two most reactive species the body produces — while leaving alone the signalling molecules your cells use for normal function. That selectivity matters more at the mitochondrial level than almost anywhere else, because mitochondria are simultaneously the body’s largest source of reactive oxygen species and the cellular machinery where every fuel-switching decision actually happens.
There’s a practical question worth addressing: does inhaled hydrogen actually reach metabolic tissue? Animal studies that have mapped where inhaled hydrogen distributes after inhalation have shown it reaches liver, skeletal muscle, mesentery fat, and brain in measurable concentrations within minutes — Ryo Yamamoto and colleagues from Keio University published the most-cited tissue-distribution data on this in Scientific Reports in 2019. A separate 2020 study in the Journal of Clinical Medicine Research by Motoaki Sano confirmed, in an animal model, that low-flow nasal cannula delivery — the route every machine on this page uses — produces blood hydrogen concentrations comparable to what the wider literature considers physiologically active.
A note on the evidence base in the spirit of honesty. The direct human inhalation research on metabolic outcomes in healthy adults is small — Grepl 2025 is the only sizeable trial. There’s a much larger evidence base on hydrogen-rich water in named-condition populations which we won’t claim translates directly to general metabolic health in healthy people. What’s emerging across the picture is that the mechanism story is well-developed, the tissue-distribution question has been answered, and the early human inhalation evidence is moving in the direction the mechanism predicted. The long-term outcomes work in healthy adults is still being done.
The Mechanism
How it might work.
Molecular hydrogen is the smallest molecule in the universe. It can cross cell membranes without needing a receptor or a transporter, which means it reaches places larger antioxidants simply can’t. Once inside a cell, it can selectively neutralise the hydroxyl radical — the most reactive and destructive free radical the body produces — while leaving alone the signalling molecules your body relies on for normal function. That selectivity is the reason the field exists at all.
Where it matters for metabolic health is at the level of the mitochondria. Mitochondria are the cellular machinery of metabolism — they’re where the body decides, second by second, whether to burn fat or carbohydrate, how much energy to release, how much heat to produce. They’re also the body’s largest source of reactive oxygen species, simply because the process of producing energy generates them as a by-product. Healthy mitochondria handle that load without difficulty. Mitochondria under chronic oxidative stress show measurable changes in their fuel-switching behaviour — what researchers call metabolic flexibility, the ability to switch cleanly between fuels as conditions change. The hypothesis the metabolic research has been testing is whether quietly reducing hydroxyl radical activity at the mitochondrial level may help preserve that flexibility.
There’s a practical question worth addressing: does inhalation at the flow rates our machines use actually deliver enough hydrogen to matter at the tissue level? The Sano 2020 study answered the delivery question directly — in an animal model, pure hydrogen through a standard nasal cannula at 250 ml/min produced arterial hydrogen concentrations comparable to levels the wider literature considers physiologically active. The Hydro Nova delivers 1500 ml/min — more than six times that rate. The Yamamoto 2019 tissue-distribution work answered where it actually goes once delivered: hydrogen reached liver, kidney, mesentery fat, and skeletal muscle in measurable concentrations within minutes of inhalation in animal studies.
Why fat oxidation specifically might shift is worth a word. A respiratory exchange ratio between 0.7 and 1.0 reflects the body’s moment-by-moment fuel preference — 0.7 is almost pure fat, 1.0 is almost pure carbohydrate. People who consistently sit higher in RER at rest tend to have less metabolic flexibility than people who sit lower. The Grepl 2025 finding — that hydrogen inhalation shifted RER downward across an entire 60-minute session in healthy active women — sits exactly where the mechanism predicts it would. Whether that single-hour shift translates into anything noticeable over weeks and months is what the field is still working out.
What It Feels Like
What it feels like.
Sarah K. came to hydrogen therapy from curiosity rather than urgency. She’d been reading about it for a while — the kind of person who notices a new thread of research and follows it for a few months before deciding whether to act on it. When she decided, she chose the Hydro Nova and started a daily practice without a strong expectation of what would happen.
“I was blown away. After just a few sessions, I started noticing real shifts — more steady through the day, less foggy, the kind of changes that felt like my body was working with me rather than against me.”
— Sarah K., customer
She has been careful, in her own way of telling the story, not to overclaim. She talks about feeling steadier. Less foggy. A sense of the day having a more even texture than it had before — fewer of the dips she’d come to think of as part of how her body worked. She doesn’t make medical claims about what changed, and we won’t make them on her behalf. What she describes is the subjective experience of attention to her own daily fuel handling — the quieter, more interesting thing that some of our customers describe after a few months of daily practice.
That register — attention to the texture of the day, rather than focus on a specific outcome — is one of the patterns we see most often on this page’s audience. People who already do the obvious things. Who read the research carefully. Who are curious about what comes next without being desperate for it. Many users report a similar quality to Sarah’s description: nothing dramatic, nothing announced, but something that registers as different from how things felt before.
Customer of H2 Pure Life — written consent on file.
Daily Practice
Where it fits in your day.
The simplest pattern for metabolic support is the most common: thirty to sixty minutes a day, no specific time of day required. The Grepl 2025 trial used a single 60-minute session and measured effects within the hour. The customers who use it for general metabolic wellbeing tend to settle into it as a daily practice indefinitely, not as a fixed-duration intervention.
Timing relative to meals is a question that comes up. Some customers report finding it useful in the post-meal window, when the body is doing the most fuel-handling work. Others prefer the fasted state in the morning, before the day’s first input arrives. The research hasn’t established an optimal protocol — both patterns are reasonable, and the right one is whichever fits your day without becoming a thing you have to remember.
It layers well with the other things that support metabolic health. Movement, sleep, the obvious cardiovascular hygiene that everybody knows about. The hydrogen is one input alongside others — not a replacement for any of them, and not the kind of thing that does its work in isolation. Most of our customers describe it as part of how they look after themselves rather than as a single act of attention.
A word on machine fit. Most users on this page settle into the Hydro Nova at 1500 ml/min. That flow rate puts it at the dose serious research uses — not the minimum that has been tested. The Grepl 2025 trial used 300 ml/min and found effects, which means even the Hydro Gen at 900 ml/min sits well above the dose the research has explored. The Hydro Medic at 3000 ml/min is for those who want the highest flow rate the research has tested.
None of which is a prescription. Daily practice. The work happens quietly.
Is It Right For You?
Is it right for you?
This isn’t a treatment. It isn’t a cure. It isn’t medicine. It isn’t a weight-loss intervention. What it is, for the people it suits, is a quietly considered piece of wellness technology — and the early research on what 60 minutes of molecular hydrogen does to resting metabolism is interesting enough to be worth knowing about.
If you already feel steady through the day, you probably don’t need this. If you’re the kind of person who notices the texture of your daily energy — who pays attention to how you feel between meals, who reads the research carefully, who already does the obvious things, who is curious about what comes next without being desperate for it — that’s where hydrogen therapy may be worth exploring. Sarah is one of those people. Many of our customers are.
The Grepl 2025 trial is a beginning, not an endpoint. The mechanism is well-supported by primary research, including the foundational Nature Medicine paper that the field is still building on. The wider research base on hydrogen and metabolic outcomes has mostly been in named-condition populations — which is one click away on the research page if you want to read it carefully. The long-term human outcomes work in healthy adults is still being done. We think the trajectory of the science is genuinely promising. We also think the only honest position is to say: we believe this is worth looking at carefully, and we’ll let the research speak for itself.
The Hydro Nova is the machine we built around the question of flow rate. The dose serious research uses — not the minimum that has been tested. Where the research sits is where the marketing usually doesn’t. That’s where we’ve tried to be.
If you’d rather hear how this fits into daily life, our customers have shared their experiences in their own words.